Skip to main content

The Pan.bio Platform

One end-to-end, AI-powered platform for every step of genomic analysis, from raw sequencing data to clinical reports to cohort discovery.

Platform

One Platform.
Every Step of
Genomic Analysis.

From raw sequencing data to clinical reports to cohort discovery, Pan.bio brings the entire genomic workflow into a single AI-powered platform; so teams stop stitching tools together and start delivering results.

Bioinformatics Pipelines — From Raw Data to Reliable Results. In Clicks, Not Code
Bioinformatics Pipelines

From Raw Data to Reliable Results. In Clicks, Not Code

Validated nf-core pipelines from raw sequencing data to reproducible insights. Automated for reliability, with Notebooks for deeper exploration.

Notebooks — Explore. Experiment. Standardize.
Notebooks

Explore. Experiment. Standardize.

A pre-configured notebook environment where BioMind generates code, debugs errors, and helps turn one-off discoveries into reusable team workflows.

VAIC — Variant Interpretation & Classification
VAIC

Variant Interpretation & Classification

Guideline-aware clinical variant classification powered by ACMG/AMP, CanVIG, ACGS, and ClinGen. AI-assisted, human-controlled.

Patient Cohorts — A Marketplace for Real-World Patient Data
Patient Cohorts

A Marketplace for Real-World Patient Data

Connecting hospitals and labs with pharma and biotech researchers. Unlock underrepresented populations while keeping data under provider ownership at every step.

About Pan.bio

Built to translate the language of life

Pan.bio exists to empower scientists to transform genomic data into scientific breakthroughs. We build the AI-powered, end-to-end platform that bridges the distance between raw sequences and world-changing insights, making genomic research faster, more accurate, and accessible to teams who've been left out of the global research conversation for too long.

Our focus on underrepresented populations isn't a marketing line, it's the reason we exist. From MENA breast cancer research to Pan-Arab diabetes cohorts, we're building the infrastructure that lets clinicians, researchers, and pharma teams generate the genomic insights their populations have been missing from for decades.

"We're not just building software, we're building equity in genomics."

The Pan.bio Team

0

researchers trust Pan.bio to power their genomic discovery

No credit card required  ·  Start in minutes